Hüppa põhisisu juurde
Raamatukoi
Tõde ja õigus

Molecular and Cell Biology of Human Gene Therapeutics

G. Dickson (toim.) · Springer · 2013

Molecular and Cell Biology of Human Gene Therapeutics

advanced metastatic disease of solid tumors, dictates that each tumor mass, indeed each individual metastasis, will have a unique antigen and cytokine environment and hence unique response to immune modu lation. A
differential response to immunotherapy is thus inevitable. 4. Many of the human trials described are not randomized and report survival or response against historical controls. Most tumors described are immunogenic human
tumors: renal cell cancer and melanoma are most common. In order to avoid the well-described inter-patient vari ation and rare incidence of spontaneous response among patient samples as well as selection bias and changes in
practice over time, randomized trials are required. 5. Immunological treatment is unlike conventional chemotherapy in its endpoint. Most chemotherapeutic regimes require a complete response or a good partial response for cure
or good palliation. There are now many cases where immunotherapy has provided long-term palliation without massive tumor reduction. Immunity may be stimulated to a degree which holds tumorigenicity in check and most
importantly, pro vides good palliation for the patient in a manner that differs essentially from chemotherapy.

Saadavus
254,00 €

Uus kasutamata raamat

Täna tellides on tarneaeg umbes 10 päeva (27.11.2026)Tellimuse täitmise aeg on umbkaudne ja sõltub nädalapäevast, millal tellimus tehakse. Reeglina ei kulu üle kahe nädala.

Tarne ja kättesaamine

Detailid

Autor
G. Dickson (toim.)
ISBN
9789401042420
Aasta
2013
Kirjastus
Springer
Keel
inglise
Köide
Pehme kaas
Lehekülgi
403
Teema
Meditsiin › Prekliinilised alusteadused — Pre-clinical medicine: basic sciences
Kaal
638 g